Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 9:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1945–1968 of 3,919 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hypertension Clear all

Conditions: Desaturation, Bradycardia, Tachycardia, Hypertension, Hypotension
Interventions: Rapid Response Team (NTX wireless monitoring system); Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Glaucoma, Open-Angle
Interventions: Netarsudil Ophthalmic; Drug
Lead sponsor: University of the Incarnate Word; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Hypertension
Interventions: irbesartan, placebo, PS433540; Drug
Lead sponsor: Ligand Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 40
States / cities: Pell City, Alabama • Tempe, Arizona • Tucson, Arizona + 36 more

Conditions: Hypertension, Renovascular
Interventions: qMT-MRI to detect fibrosis.; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 40 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: Not listed
Lead sponsor: VeraLight, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Hyattsville, Maryland

Conditions: Glaucoma
Interventions: Eyelid closure, No intervention will be assigned; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Primary Open Angle Glaucoma
Interventions: Placement of the sponge, Mitomycin-C; Procedure · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Healthy
Interventions: Not listed
Lead sponsor: Kara Whitaker; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: Iowa City, Iowa • Pittsburgh, Pennsylvania • Morgantown, West Virginia

Conditions: Hypertension, Pure Autonomic Failure, Multiple System Atrophy, Autonomic Failure
Interventions: Passive heat stress, Control (non-heating); Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Pulmonary Hypertension
Interventions: Optison (Perflutren Protein-Type A Microspheres Injectable Suspension), Dextrose; Drug
Lead sponsor: GE Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Elliott, Maryland

Conditions: Aortic Dissection, Hypertension
Interventions: Withings Digital Blood Pressure Monitor; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Fluid Overload and Hypertension in Hemodialysis Patients
Interventions: 5% dextrose solution; Other
Lead sponsor: Renal Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension
Interventions: fenoldopam, Placebo; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 70 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Renal Artery Stenosis, Kidney Diseases, Hypertension
Interventions: Not listed
Lead sponsor: Central Coast Cardiovascular Research; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Salinas, California

Conditions: Renal Insufficiency, Chronic
Interventions: 6R-BH4, 6R-BH4 placebo, Folic acid, Exercise training, Stretching, Histidine and beta-alanine supplementation, Histidine and beta-alanine placebo; Drug · Other · Dietary Supplement
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 3
States / cities: Atlanta, Georgia • Decatur, Georgia

Conditions: Hypertension, Medication Non-Adherence
Interventions: SMASH, Enhanced SC; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 59 Years
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Pulmonary; Hypertension, Heart Failure, Preserved Ejection Fraction
Interventions: 15N Nitrate, 14N Nitrate; Drug
Lead sponsor: Gladwin, Mark, MD; Individual
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Cardiovascular Diseases, Heart Diseases, Hypertension
Interventions: Mindfulness Meditation (MM) Program, Health Education Control Program (CTL), Lifeskills Program (LP); Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 14 Years to 17 Years
Enrollment: 283 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Cirrhosis, Liver, Portal Hypertension, Ascites Hepatic
Interventions: Withings Home Blood Pressure Device and Scale, Standard of Care; Device · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hypertension
Interventions: Remote Intervention; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Hypertension Pulmonary Secondary, Heart Failure, Right Sided, Heart Failure With Normal Ejection Fraction
Interventions: Levosimendan, Matching Placebo; Drug
Lead sponsor: Tenax Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 16
States / cities: Stanford, California • Chicago, Illinois • Boston, Massachusetts + 10 more

Conditions: Hypertension, Pulmonary
Interventions: GSK2586881; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Dallas, Texas

Conditions: Traumatic Brain Injury, Intracranial Hypertension
Interventions: Mannitol, Hypertonic Saline; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Hypertension, Pulmonary
Interventions: bosentan, Pioglitazone; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Stanford, California

Search by objective public record fields.

Validation of the NTX Wireless Patient Monitoring System

Short-term Effect of Rho-kinase Inhibitor on Retinal Circulation

A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension

A Study to Evaluate Renal Fibrosis Using MRI Techniques

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications

Eyelid Closure in Glaucoma Therapy

The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device

The Pregnancy 24/7 Cohort Study

Local Heat Stress in Autonomic Failure Patients With Supine Hypertension

Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).

Digital Home Blood Pressure Monitoring in Type B Aortic Dissection Patients

Effect of Sodium Concentration of Priming and Rinsing Fluids on Weight Gain

Effect of Gene Variants on Dopamine Receptor Natriuretic Responses

Renal Artery Contrast-Free Trial

Neurovascular Transduction During Exercise in Chronic Kidney Disease

Patient Centered Health Technology Medication Adherence Program for African American Hypertensives

A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection Fraction

Effects of Behavioral Stress Reduction Programs on Blood Pressure in African American Youth

A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients

Cardiovascular Precision Medicine & Remote Intervention

Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF

A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH)

Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients

Insulin Resistance in Pulmonary Arterial Hypertension